![Chemical structure of N-[(2E)-3-methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene]acetamide, CAS 554-57-4](https://api.angenesci.com/structure/1614/554-57-4.png)
No data
No data
No data
| CAS Number | 554-57-4 |
| Catalog Number | AG00DEQE(AGN-PC-0SJ4UC) |
| Chemical Name | N-[(2E)-3-methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene]acetamide |
| EC Number | 209-066-7 |
| IUPAC Name | N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide |
| InChI | InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12) |
| InChI Key | FLOSMHQXBMRNHR-UHFFFAOYSA-N |
| MDL Number | MFCD00083416 |
| Molecular Formula | C5H8N4O3S2 |
| Molecular Weight | 236.2720 |
| NSC Number | 758426 |
| SMILES | CC(/N=C1SC(S(N)(=O)=O)=NN/1C)=O |
| Synonyms | Methazolamide,
N Methylacetazolamide,
N-Methylacetazolamide,
methazolamide,
554-57-4,
Methenamide,
Neptazane,
Neptazaneat,
Metazolamida,
Methazolamidum,
Naptazane,
Metazolamide [DCIT],
Metazolamida [INN-Spanish],
Methazolamidum [INN-Latin],
UNII-W733B0S9SD,
C5H8N4O3S2,
CHEBI:6822,
N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide,
HSDB 3269,
EINECS 209-066-7,
BRN 0232387,
UNII-DA43GW06P1,
MLS000028532,
CHEMBL288100,
DA43GW06P1,
W733B0S9SD,
Acetamide, N-(5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-,
Acetamide, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]-,
NCGC00016508-01,
Metazolamide,
CAS-554-57-4,
SMR000058287,
2-Acetylimino-3-methyl-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide,
5-Acetylimino-4-methyl-delta(sup 2)-1,3,4-thiadiazoline-2-sulfonamide,
N-(4-Methyl-2-sulfamoyl-delta(sup 2)-1,3,4-thiadiazolin-5-ylidene)acetamide,
L584601,
N-(3-methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene)acetamide,
Acetamide, N-(4-methyl-2-sulfamoyl-delta(sup 2)-1,3,4-thiadiazolin-5-ylidene)-,
N-[(2E)-5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide,
SR-05000001844,
Methazolamid,
Methazolamide [INN:BAN:JAN],
2-Acetylimino-3-methyl-.delta.(4)-1,3,4-thiadiazoline-5-sulfonamide,
3-methyl-2-(2-oxo-1-azapropylidene)-1,3,4-thiadiazoline-5-sulfonamide,
5-Acetylimino-4-methyl-.delta.(2)-1,3,4-thiadiazoline-2-sulfonamide,
N-(4-Methyl-2-sulfamoyl-.delta.2-1,3,4-thiadiazolin-5-ylidene)acetamide,
N-(5-(Aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide #,
Acetamide, N-(4-methyl-2-sulfamoyl-.delta.2-1,3,4-thiadiazolin-5-ylidene)-,
Neptazane (TN),
Methazolamide,(S),
Methazolamide [USP:INN:BAN:JAN],
Methazolamide, MZA,
Prestwick_1007,
Methazolamide (MZA),
Methazolamide, (Z)-,
Spectrum_001615,
Opera_ID_717,
AC1L1HEV,
CHEMBL19,
MZA3,
Prestwick0_000802,
Prestwick1_000802,
Prestwick2_000802,
Prestwick3_000802,
Spectrum2_001543,
Spectrum3_001914,
Spectrum4_000190,
Spectrum5_001006,
DSSTox_CID_3281,
cid_4100,
DSSTox_RID_76956,
DSSTox_GSID_23281,
Oprea1_161738,
SCHEMBL24686,
SCHEMBL24687,
BSPBio_000663,
BSPBio_003508,
KBioGR_000739,
KBioSS_002095,
4-27-00-08221 (Beilstein Handbook Reference),
MLS001146905,
DivK1c_000582,
SPECTRUM1503252,
SPBio_001386,
SPBio_002584,
AC1Q40D8,
AC1Q40D9,
BPBio1_000731,
GTPL6828,
Methazolamide (JAN/USP/INN),
US10172837, Methazolamide,
CHEMBL1335656,
DTXSID1023281,
SCHEMBL13825893,
BDBM10881,
CHEBI:94513,
CTK8G0825,
HMS501N04,
KBio1_000582,
KBio2_002095,
KBio2_004663,
KBio2_007231,
KBio3_003013,
FLOSMHQXBMRNHR-DAXSKMNVSA-N,
FLOSMHQXBMRNHR-QPJJXVBHSA-N,
FLOSMHQXBMRNHR-UHFFFAOYSA-N,
Methazolamide, >=98% (HPLC),
NINDS_000582,
BDBM315269,
HMS1570B05,
HMS1922M19,
HMS2093A05,
HMS2097B05,
HMS2234L03,
HMS3259H05,
HMS3372G12,
HMS3652E21,
HMS3714B05,
Pharmakon1600-01503252,
EBD27355,
HY-B0553,
KS-000010PT,
Tox21_110464,
BDBM50013792,
CCG-39321,
MFCD00083416,
NSC758426,
SBB037875,
ZINC12503151,
AKOS015897587,
AKOS024464790,
AKOS026749792,
N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide,
ZINC100019188,
ZINC253917094,
CL 8490,
CS-2658,
DB00703,
FCH4114988,
KS-5328,
MCULE-1665001985,
NC00618,
NSC-758426,
SB17307,
IDI1_000582,
NCGC00018188-01,
NCGC00018188-02,
NCGC00018188-03,
NCGC00018188-04,
NCGC00018188-05,
NCGC00018188-06,
NCGC00018188-07,
NCGC00022950-03,
NCGC00022950-04,
NCGC00178022-01,
NCGC00178022-02,
AK163546,
AN-45878,
AS-13272,
CC-30264,
CPD001453721,
CPD001496938,
H773,
LS-10006,
SAM002548986,
SAM002589943,
ST081366,
SBI-0051804.P002,
AB0013250,
A4364,
AB00490015,
FT-0603467,
S4039,
SW197085-3,
C07764,
D00655,
K-9905,
AB00052336_04,
554M574,
A830656,
Methazolamide, VETRANAL(TM), analytical standard,
I09-1225,
L 584601,
SR-05000001844-1,
SR-05000001844-2,
SR-05000001844-3,
BRD-K13356952-001-15-2,
BRD-K71053238-001-03-6,
BRD-K71053238-001-04-4,
(E)-N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene,
N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)ethanamide,
Methazolamide, United States Pharmacopeia (USP) Reference Standard,
(E)-N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide,
5-Acetylimino-4-methyl-| currency2-1,3,4-thiadiazoline-2-sulfonamide,
Acetamide, N-(5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-, (N(Z))-,
N-(4-Methyl-2-sulfamoyl-| currency2-1,3,4-thiadiazolin-5-ylidene) acetamide,
N-(4-Methyl-2-sulfamoyl-| currency2-1,3,4-thiadiazolin-5-ylidene)acetamide,
N-[(2E)-3-Methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene]acetamide,
N-[(2Z)-3-methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene]acetamide,
1164547-86-7,
N-Methylacetazolamide,
Sulfonamide 2,
Sulfonamide, 2,
N Methylacetazolamide,
D0C2II,
Methazolamide [BAN:INN:JAN],
CID4100,
C5-H8-N4-O3-S2,
CS-O-11690,
Methazolamide (oral, sustained release),
D008704,
N-(3-Methyl-5-Sulfamoyl-1,3,4-Thiadiazol-2(3h)-Ylidene)acetamide,
N-(4-methyl-2-sulfamoyl-delta-2-1,3,4-thiadiazolin-5-ylidene)acetamide,
''N''-(3-Methyl-5-sulfamoyl-3''H''-1,3,4-thiadiazol-2-ylidene) ethanamide,
Acetamide, N-(4-methyl-2-sulfamoyl-delta(2)-1,3,4-thiadiazolin-5-ylidene)-,
MZM,
|
| Complexity | 419 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 236.004g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 14 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 236.264g/mol |
| Monoisotopic Mass | 236.004g/mol |
| Rotatable Bond Count | 1 |
| Topological Polar Surface Area | 139A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 0.1 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H312-H332 |
| Packing Group | |
| Precautionary statements | P280 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

